The Modern Self-Care Consumer Is More Sophisticated Than Your Current OTC Marketing Assumes

A Growing Market With a More Demanding Consumer at the Centre of It

The OTC consumer health market is expanding with both speed and structural depth. Global revenues are projected at USD 362 billion in 2026 and on track to reach USD 720 billion by 2035, driven by rising health awareness, the sustained acceleration of self-care behaviours, and a fundamental shift in how people access and manage their own health. What began as a pandemic-era behavioural change has settled into something more permanent: consumers are taking ownership of their health with a level of engagement and information literacy that previous generations simply did not have.

For OTC brand managers and consumer health marketing leaders, this is a real and significant commercial opportunity. But it also creates a more complex and demanding marketing environment. The consumer making purchasing decisions in this space in 2026 is better informed, more sceptical of generic claims, more digitally connected, and more specific in what they want from a health product than at any point in the history of this category. The brands understanding and responding to that shift are gaining meaningful ground. The ones still relying on broad awareness advertising and legacy category positioning are losing shelf space they may not recover.

Self-Care Has Become Specific. Your Messaging Needs to Match.

The shift toward self-medication and preventive health management is well established. According to data from Pfizer, 81% of consumers now reach for an OTC product as their first response to a minor ailment, a behavioural pattern significant enough to have a measurable impact on GP and physician consultation volumes in primary care. But the nature of that self-care behaviour is becoming increasingly specific and functionally oriented, and that changes what effective OTC marketing needs to do.

Today's consumer is not simply seeking symptom relief. A growing share of purchases in the vitamins, minerals, and supplements category, now growing at a CAGR of 7.52%, are being driven by specific functional outcomes: sleep quality, cognitive performance, stress management, immune resilience, and gut health. The language that resonates in this segment mirrors the precision of technology marketing more than traditional healthcare advertising: specific outcomes, specific ingredients, specific audiences, and credible evidence to support the claims.

Gut health is among the fastest-growing sub-categories in the OTC space, with digestive health applications projected to grow at a CAGR of 8.1% through 2034. The combination of rising clinical incidence, lifestyle factors, and significantly amplified consumer awareness around the gut-brain connection has created a category with real, sustained demand and genuine positioning opportunity for brands that can occupy it with credibility and consistency.

GLP-1 Adoption Is Creating a New Category of Consumer Health Demand

One of the most consequential emerging forces reshaping OTC and supplement marketing right now is the rapid expansion of GLP-1 medications. As adoption of drugs like Mounjaro and Wegovy continues to grow, with nearly 27% of Americans who have weight loss goals in 2026 planning to use GLP-1 medication, these treatments are materially changing what consumers eat, which supplements they need, and how they engage with health products more broadly.

Because GLP-1 medications significantly suppress appetite and alter nutrient absorption patterns, patients face genuine risks of nutritional deficiency without targeted supplementation. This is creating a real and growing demand for condition-specific OTC nutrition products designed to support GLP-1 users throughout their treatment journey. Brands that move quickly to occupy this space with clinically credible, specifically positioned products will have a genuine first-mover advantage in a category that has significant long-term growth ahead of it.

The regulatory context is also becoming more favourable for category expansion. The FDA's finalisation of the Additional Condition of Non-prescription Use rule in late 2024 has opened new pathways for more complex molecules to transition to OTC status. For companies with strong commercial capabilities and disciplined regulatory planning, this is an opportunity to build meaningful category leadership in emerging segments before the competitive field fills in.

Digital Has Moved from a Channel to a Commercial Foundation

Online sales are projected to account for nearly 25% of total OTC pharmaceutical revenues in 2026, with the pharmaceutical e-commerce market growing at a CAGR of 11.62%. The boundary between offline and online retail is effectively dissolving in the consumer health category, and cross-channel experience consistency is no longer a competitive differentiator. It is a baseline commercial requirement. Brands that have not built seamless, data-informed cross-channel consumer journeys are already operating behind the curve.

Investment in digital marketing has accelerated significantly across the category. Companies spent 15% more on digital campaigns in 2025 than in the prior year, reaching health-conscious, digitally native consumers who make purchase decisions based on ingredient transparency, peer reviews, and trusted health community endorsements as much as on brand familiarity. For OTC brands with strong clinical foundations and established consumer equity, the challenge is translating that credibility into a digital presence that earns the trust of a new generation of buyers without abandoning the signals that have built confidence over decades.

Clean Label and Sustainability Are Now Table Stakes, Not Points of Difference

Consumer demand for natural, clean-label formulations has moved decisively past trend status. In 2026, ingredient transparency and the removal of legacy chemical formulations are purchase drivers that directly affect category selection, brand preference, and willingness to pay a premium. Brands like Native and TheraBreath have demonstrated that positioning built around ingredient clarity and formulation honesty can displace long-established incumbents in categories that had been stable for years. The broader OTC market is tracking a similar trajectory.

Sustainability expectations are following the same path. Major category players including Advil, Bayer, Sanofi, and Haleon are investing in sustainable packaging through programmes like the Blister Pack Collective and individual plastic reduction commitments. For mid-size OTC brands, this is both a consumer expectation to meet and a marketing narrative to build, but only when told with specificity and verifiable credibility rather than broad environmental claims that consumers have become very adept at discounting.

Building OTC Brands That Are Built for Where the Consumer Is Going

The OTC and consumer health brands performing best in 2026 have shifted their commercial thinking in a direction that I find consistently underinvested in this sector. They have moved from broad demographic targeting to specific condition-state and lifestyle-state messaging that respects the intelligence and specificity of the modern health consumer. They have built digital presence that generates genuine consumer trust through transparency, clinical credibility, and real-world evidence, not advertising frequency alone. And they have marketing strategies built to operate coherently across pharmacy retail, specialist wellness channels, and direct-to-consumer digital simultaneously.

At VELLUM, we work with OTC and consumer health brands to build marketing strategies that connect clinical credibility with consumer relevance and that perform across the full range of channels where self-care purchasing decisions are being made today and where they will be made tomorrow.

Ready to build an OTC brand strategy that connects with the modern health consumer? Contact VELLUM today.

About VELLUM Global

VELLUM is a life sciences-focused marketing agency serving companies across Medical Devices & Diagnostics, Pharmaceuticals & Biologics, OTC & Consumer Health, Cosmetics & Specialty Chemicals, Food & Nutritional Supplements, Laboratory Equipment & Scientific Instruments, CDMOs & Manufacturing Organizations, and Regulatory & Consulting Organizations. We combine strategic intelligence, scientific credibility, and marketing craft to help our clients build meaningful brands, generate qualified leads, and grow commercially in one of the world's most consequential industries.